Repurposing Interleukin-6 Inhibitors to Combat COVID-19 by Shumei Kato, Razelle Kurzrock

Get full text

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers by Diviya Gupta, Shumei Kato, Razelle Kurzrock

Get full text

Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken by Mina Nikanjam, Shumei Kato, Razelle Kurzrock

Get full text

Liquid biopsy: current technology and clinical applications by Mina Nikanjam, Shumei Kato, Razelle Kurzrock

Get full text

Targeting KRAS: Crossroads of Signaling and Immune Inhibition by Shumei Kato, Yu Fujiwara, David S. Hong

Get full text

179 Immunotherapy trials lack a biomarker for inclusion: implications for drug development by Razelle Kurzrock, Shumei Kato, Jacob Adashek, Alexey Goloubev

The paradox of cancer genes in non-malignant conditions: implications for precision medicine by Jacob J. Adashek, Shumei Kato, Scott M. Lippman, Razelle Kurzrock

Get full text

Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer by Jacob J. Adashek, Yadis Arroyo-Martinez, Arjun K. Menta, Razelle Kurzrock, Shumei Kato

Get full text

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population by Shai Rosenberg, Gil Ben Cohen, Shumei Kato, Ryosuke Okamura, Scott M. Lippman, Razelle Kurzrock

Get full text

SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer by Gregory P. Botta, Shumei Kato, Hitendra Patel, Paul Fanta, Suzanna Lee, Ryosuke Okamura, Razelle Kurzrock

Get full text

Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown by Shumei Kato, Sophia Gumas, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Jason K. Sicklick, Razelle Kurzrock

Get full text

ALK fusions in the pan-cancer setting: another tumor-agnostic target? by Aditya Shreenivas, Filip Janku, Mohamed A. Gouda, Hui-Zi Chen, Ben George, Shumei Kato, Razelle Kurzrock

Get full text

Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer by Jacob J. Adashek, Chinmayi Pandya, Nicholas J. Maragakis, Pradip De, Philip R. Cohen, Shumei Kato, Razelle Kurzrock

Get full text

Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response by Hanna E. Persha, Shumei Kato, Pradip De, Jacob J. Adashek, Jason K. Sicklick, Vivek Subbiah, Razelle Kurzrock

Get full text

Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies by Diviya Gupta, Razelle Kurzrock, Suzanna Lee, Ryosuke Okamura, Hyo Jeong Lim, Ki Hwan Kim, Jason K. Sicklick, Shumei Kato

Get full text

Precision medicine‐based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience by Bryan H. Louie, Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Suzanna Lee, Ryosuke Okamura, Paul T. Fanta, Razelle Kurzrock

Get full text

Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis by Justin Shaya, Shumei Kato, Jacob J. Adashek, Hitendra Patel, Paul T. Fanta, Gregory P. Botta, Jason K. Sicklick, Razelle Kurzrock

Get full text

48 Blood-based peripheral T cell cytotoxicity assay in predicting response to immune checkpoint inhibitors: a US pilot study by Yali Li, Rajesh Nair, Shumei Kato, Suzanna Lee, Kota Iwahori, Jonathon Woo, Michele Baltay, Junichi Akatsuka, Srinath Sampath, Christian Schmedt, Srihari Sampath

Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies by Aaron M. Goodman, Shumei Kato, Philip R. Cohen, Amélie Boichard, Garrett Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock

Get full text

High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome by Nithya Krishnamurthy, Daisuke Nishizaki, Scott M. Lippman, Hirotaka Miyashita, Mary K. Nesline, Sarabjot Pabla, Jeffrey M. Conroy, Paul DePietro, Shumei Kato, Razelle Kurzrock

Get full text